Russell Investments Group
SGYP

Russell Investments Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Russell Investments Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-219,625
Closed -$1.02M – 3103
2017
Q1 		$1.02M Buy
219,625
+23,278
+12% +$135K ﹤0.01% 2084
2016
Q4 		$1.16M Buy
+196,347
New +$1.03M ﹤0.01% 2102

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group's SGYP Position: Q2 2017 in Review

Russell Investments Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 219,625 shares — an estimated $1.02M sold.

Russell Investments Group first reported a position in SGYP in Q4 2016 and held it in 2 quarters. The position peaked at $1.16M in Q4 2016. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

  • Russell Investments Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
  • Russell Investments Group sold 219,625 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $1.02M.
  • Russell Investments Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 2 quarters.
  • Russell Investments Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.16M in Q4 2016.
  • 146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Russell Investments Group's 13F filing for Q2 2017, filed 25 Jul 2017.